Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study - Concepedia

Concepedia

Publication | Open Access

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

DOI Full Paper Access

59

Citations

19

References

2021

Year

Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán, Enrique Álvarez, M. V. Davydovskaya, Silvia Delgado, Evgeniy Evdoshenko, Nataša Giedraitienė, Katrin Gross‐Paju, Sulev Haldre,

Multiple Sclerosis Journal

Abstract

Ofatumumab 20 mg q4w self-administered subcutaneously via autoinjector is bioequivalent to PFS administration and provides rapid B-cell depletion.

References

	Year	Citations

Page 1